News

A registered dietitian answers key questions about fiber — why we need it, how much we need to consume, whether supplements ...
In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...
Researchers also found that about one-third of teens undergoing weight-loss surgery had a body mass index (BMI) of more than ...
The strategy of rewiring the brain's stress response is rooted in two pieces of scientific literature. One is biochemical.
Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus." ...
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...
A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...
Injected weight-loss drugs Wegovy, from Novo Nordisk, and Eli Lilly's Zepbound have U.S. list prices of over $1,000 a month.
The best metric is not weight, but a particularly toxic kind of fat.
Scientists test Mounjaro and Wegovy - the big beasts of weight loss medication - to see which is best.